Gates, Wellcome bet $40M on Kymab’s antibody…


Cambridge, U.K.’s Kymab touts its drug development platform as an ideal way to spotlight new antibodies, and some bright minds would seem to agree, as the Wellcome Trust and Bill and Melinda Gates Foundation have teamed up on a $40 million round for the biotech. Under the Series B terms, each organization will hand over $20 million to support the company’s Kymouse technology, a genetically engineered mouse…
Read More
Seattle BioMed receives $10M NIAID grant to lead A…
The National Institute of Allergy and Infectious Diseases has awarded a 7-year, $9.8 million grant to develop an AIDS vaccine to four Seattle-based research organizations and Rockefeller University. AIDS or acquired immunodeficiency syndrome is a life threatening and chronic condition.Click for more information about AIDS here. The disease damages your immune system and interferes with the ability of the body to fight the organisms that cause the disease. HIV is a disease that gets transmitted sexually. It spreads when one comes in contact with blood that is already infected. The nonprofit Seattle Biomedical Research Institute will lead the research team, which will be made up of researchers from the University of Washington, Fred Hutchinson Cancer Research Center, Seattle Children’s Hospital and…
Read More
12th Vaccines Research & Development: All Thi…
GTC is proud to present its 12th Vaccines Research & Development: All Things Considered Conference, to be held in Boston, MA on July 9-11, 2014. This conference continues a tradition of presenting valuable updates and exposure to all aspects of vaccine development, including research, product design considerations / specifications, manufacturing, regulations, investment, and policy, in a comfortable, interactive and…
Read More
HIV immune discovery
A new discovery that explains how the body’s immune system makes a potent antibody that blocks HIV infection may be an important step toward developing a vaccine against the virus. Scientists from the National Institute of Allergy and Infectious Diseases analyzed data from the results of a clinical trial of the only experimental HIV vaccine to date that’s shown modest success in people. Trial results showed that…
Read More
Key indicator of heart diseases
A team that includes Dartmouth College researchers has discovered a new way to detect cardiolipin, a key indicator of heart diseases and some genetic disorders. The results, which appear in the journal Analytical Chemistry, may eventually help to diagnose these conditions earlier on and to provide real-time monitoring of cardiolipin levels. Cardiolipin is a unique lipid of mitochondria, the cell structures that generate…
Read More
NIH announces $100M for new HIV research initiativ…
The Obama administration announced Monday afternoon that the National Institutes of Health will redirect $100 million in funding to establish a new, three-year program to find better treatments–and eventually, a cure–for HIV and AIDS. Dubbed the HIV Cure Initiative, the new investment is meant to spark basic research in this area, which is expected to benefit AIDS research in general, as well as research on other…

Share:

You might also like …